Walleye Capital LLC Athira Pharma, Inc. Transaction History

Walleye Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$2.74 - $13.43 $289,681 - $1.42 Million	-105,723 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$8.96 - $13.51 $947,278 - $1.43 Million	105,723 New	105,723 $1.43 Million
Q3 2021 Nov 15, 2021	SELL	$9.15 - $11.09 $424,752 - $514,808	-46,421 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$10.24 - $20.87 $475,351 - $968,806	46,421 New	46,421 $475,000

16.9M

112K

68K

Ticker ATHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,817,700
Market Cap $23.4M
Description
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.